nm23-H1 Gene and Chemotherapy Sensitivity in Oesophageal Cancer
Author Information
Author(s): Iizuka N, Hirose K, Noma T, Hazama S, Tangoku A, Hayashi H, Abe T, Yamamoto K, Oka M
Primary Institution: Yamaguchi University School of Medicine
Hypothesis
The study aims to evaluate the role of nm23-H1 in responsiveness to cisplatin-based chemotherapy in patients with oesophageal squamous cell carcinoma.
Conclusion
Reduced expression of nm23-H1 may be associated with resistance to cisplatin, indicating its potential as a prognostic marker for patients undergoing chemotherapy.
Supporting Evidence
- 46.9% of patients were positive for nm23-H1 staining.
- Overall survival rates were significantly shorter for nm23-H1-negative patients.
- Multivariate analysis showed nm23-H1 expression was the most significant factor for overall survival.
Takeaway
This study found that patients with a certain gene (nm23-H1) are more likely to respond well to a cancer treatment called cisplatin.
Methodology
The expression of nm23-H1 protein was examined immunohistochemically in patients who underwent adjuvant chemotherapy, and a cell line was transfected to study the effects on drug resistance.
Statistical Information
P-Value
0.0007
Statistical Significance
p<0.01
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website